We initially chose to use a T50A, S54A double mutant of Mycn because either mutant alone causes at least a 5-fold extension of protein half-life [53], which mimics the frequent overexpression and occasional amplification of MYCN in human medulloblastoma. This evidence concerns the gene MYCN and medulloblastoma.